Literature DB >> 9249619

A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease.

A R Varma1, P R Talbot, J S Snowden, J J Lloyd, H J Testa, D Neary.   

Abstract

The purpose of this study was to investigate patterns of 99mTc-HMPAO single-photon emission computed tomography (SPECT) abnormality in Lewy body disease (LBD) and to compare findings with those encountered in Alzheimer's disease (AD). The study group comprised 20 consecutive patient referrals fulfilling clinical criteria for LBD. All patients had fluctuating cognitive impairment and 'subcortical' dysfunction with or without perceptuospatial and/or linguistic impairment. Six patients had asymmetrical signs of parkinsonism (three left-sided and three right-sided), and 14 patients had symmetrical features of extrapyramidal involvement. 99mTc-HMPAO SPECT imaging was performed on LBD patients and findings compared with those of 57 patients with 'probable' AD and 11 normal age-matched controls. Within the LBD and AD groups, patterns of cortical and subcortical blood-flow abnormality were compared with patterns of cognitive and neurological breakdown. LBD was associated with bilateral posterior cortical blood flow abnormality, a pattern strikingly similar to that found in AD. Within the LBD group, cortical blood-flow abnormality was found to reflect patterns of neurological dysfunction (parkinsonism) indicative of subcortical involvement. In contrast, cortical blood-flow changes did not reflect patterns of neuropsychological impairment suggestive of cortical dysfunction. Within the AD group, cortical blood-flow changes were mirrored by the pattern of neuropsychological impairment. Findings support the notion that cortical blood-flow abnormality in LBD might reflect a combination of direct cortical pathology and cortical deafferentation secondary to subcortical Lewy body pathology. It would appear that 99mTc-HMPAO SPECT imaging is of limited value in the clinical differentiation of LBD and AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249619     DOI: 10.1007/s004150050101

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

2.  [Diagnostic value of multislice perfusion CT in dementia patients].

Authors:  F Streitparth; G Wieners; A Kämena; R J Schröder; H Stiepani; T Kokocinski; R Röttgen; E Steinhagen-Thiessen; R Lenzen-Grossimlimghaus; N Hidajat
Journal:  Radiologe       Date:  2008-02       Impact factor: 0.635

3.  Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease.

Authors:  E K Doubleday; J S Snowden; A R Varma; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

4.  A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

Authors:  P R Talbot; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

5.  Imaging improves diagnosis of dementia with lewy bodies.

Authors:  Masaru Tateno; Seiju Kobayashi; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

6.  Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?

Authors:  Verena Bittner; Gerhard Ullrich; Markus Thormann; Notger G Müller; Christin Friederichs; Holger Amthauer; Hans-Jochen Heinze; Daniel M Bittner
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-09-21

7.  Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography.

Authors:  Michael R Misch; Sara Mitchell; Philip L Francis; Kayla Sherborn; Katayoun Meradje; Alicia A McNeely; Kie Honjo; Jiali Zhao; Christopher Jm Scott; Curtis B Caldwell; Lisa Ehrlich; Prathiba Shammi; Bradley J MacIntosh; Juan M Bilbao; Anthony E Lang; Sandra E Black; Mario Masellis
Journal:  Alzheimers Res Ther       Date:  2014-12-05       Impact factor: 6.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.